These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37554115)

  • 21. Outcomes of bypass and endovascular interventions for advanced femoropopliteal disease in patients with premature peripheral artery disease.
    Kim TI; Zhang Y; Cardella JA; Guzman RJ; Ochoa Chaar CI
    J Vasc Surg; 2021 Dec; 74(6):1968-1977.e3. PubMed ID: 34090986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endovascular treatment of TransAtlantic Inter-Society Consensus II D femoropopliteal lesions in patients with critical limb ischemia.
    Biagioni RB; Brandão GD; Biagioni LC; Nasser F; Burihan MC; Ingrund JC
    J Vasc Surg; 2019 May; 69(5):1510-1518. PubMed ID: 30611581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endovascular Management of Femoropopliteal In-Stent Restenosis: A Systematic Review.
    Varela DL; Armstrong EJ
    Cardiovasc Revasc Med; 2019 Oct; 20(10):915-925. PubMed ID: 30447898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Duplex Ultrasound for Diagnosis of Failing Stents Placed for Lower Extremity Arterial Occlusive Disease.
    Zheng H; Calligaro KD; Jang J; Tyagi S; Madden N; Troutman DA; Dougherty MJ
    Ann Vasc Surg; 2020 Feb; 63():269-274. PubMed ID: 31626930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of Clinical Outcomes between Endovascular Therapy with Self-Expandable Nitinol Stent and Femoral-Popliteal Bypass for Trans-Atlantic Inter-Society Consensus II C and D Femoropopliteal Lesions.
    Okuno S; Iida O; Iida T; Takahara M; Yamaoka T; Kitano I; Asai M; Masuda M; Okamoto S; Ishihara T; Nanto K; Kanda T; Tsujimura T; Matsuda Y; Mano T
    Ann Vasc Surg; 2019 May; 57():137-143. PubMed ID: 30500627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. One-Year Outcomes of Heparin-Bonded Stent-Graft Therapy for Real-World Femoropopliteal Lesions and the Association of Patency With the Prothrombotic State Based on the Prospective, Observational, Multicenter
    Iida O; Takahara M; Soga Y; Yamaoka T; Nanto S; Kuratani T; Sakata Y; Mano T
    J Endovasc Ther; 2021 Feb; 28(1):123-131. PubMed ID: 32959718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spot stenting versus full coverage stenting after endovascular therapy for femoropopliteal artery lesions.
    Tomoi Y; Soga Y; Takahara M; Fujihara M; Iida O; Kawasaki D; Ando K
    J Vasc Surg; 2019 Oct; 70(4):1166-1176. PubMed ID: 30850285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Real-World Experience With the Supera Interwoven Nitinol Stent in Femoropopliteal Arteries: Midterm Patency Results and Failure Analysis.
    Myint M; Schouten O; Bourke V; Thomas SD; Lennox AF; Varcoe RL
    J Endovasc Ther; 2016 Jun; 23(3):433-41. PubMed ID: 27004494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety, clinical outcome, and fracture rate of femoropopliteal stenting using a 4F compatible delivery system.
    Sarkadi H; Bérczi V; Kollár A; Kiss D; Jakabfi P; Végh EM; Nemes B; Merkely B; Hüttl K; Dósa E
    Eur J Vasc Endovasc Surg; 2015 Feb; 49(2):199-204. PubMed ID: 25579877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stent crush: A novel endovascular approach for treatment of complex in-stent femoropopliteal chronic total occlusion.
    Tabaza L; Janzer S; George JC
    Catheter Cardiovasc Interv; 2020 Feb; 95(2):E66-E70. PubMed ID: 31313483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-Term Patency and Clinical Outcomes of Nitinol Stenting for Femoropopliteal Atherosclerotic Disease.
    Abdoli S; Katz S; Ochoa C
    Ann Vasc Surg; 2020 Jul; 66():566-572. PubMed ID: 31705987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Covered vs Uncovered Stents for Aortoiliac and Femoropopliteal Arterial Disease: A Systematic Review and Meta-analysis.
    Hajibandeh S; Hajibandeh S; Antoniou SA; Torella F; Antoniou GA
    J Endovasc Ther; 2016 Jun; 23(3):442-52. PubMed ID: 27099281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Midterm Patency After Femoropopliteal Interventions: A Comparison of Standard and Interwoven Nitinol Stents and Drug-Coated Balloons in a Single-Center, Propensity Score-Matched Analysis.
    Steiner S; Schmidt A; Bausback Y; Piorkowski M; Werner M; Yahiaoui-Doktor M; Banning-Eichenseer U; Scheinert D
    J Endovasc Ther; 2016 Apr; 23(2):347-55. PubMed ID: 26848131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endovascular treatment of femoropopliteal arterial occlusive disease: Current techniques and limitations.
    Aru RG; Tyagi SC
    Semin Vasc Surg; 2022 Jun; 35(2):180-189. PubMed ID: 35672108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravascular ultrasound measurements after drug-eluting stent placement in femoropopliteal lesions: determining predictors of restenosis.
    Mori S; Hirano K; Nakano M; Muramatsu T; Tsukahara R; Ito Y; Ishimori H
    J Endovasc Ther; 2015 Jun; 22(3):341-9. PubMed ID: 25862363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nitinol stent implantation for femoropopliteal disease in patients on hemodialysis: results of the 3-year retrospective multicenter APOLLON study.
    Fujihara M; Higashimori A; Kato Y; Taniguchi H; Iwasaki Y; Amano T; Sumiyoshi A; Nishiya D; Yokoi Y
    Heart Vessels; 2016 Sep; 31(9):1476-83. PubMed ID: 26337619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A midterm analysis of patients who received femoropopliteal helical interwoven nitinol stents.
    Chan YC; Cheng SW; Cheung GC
    J Vasc Surg; 2020 Jun; 71(6):2048-2055. PubMed ID: 32081479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary Use of the TruePath Crossing Device for Infrainguinal Chronic Total Occlusions With Intravascular Ultrasound Evaluation.
    Soga Y; Nakamura M; Hirose K; Ito N; Tomoi Y; Hiramori S; Ando K
    J Endovasc Ther; 2018 Oct; 25(5):592-598. PubMed ID: 30117364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interventions for femoropopliteal disease: endo first, second and last?
    Bakker OJ; Moll FM
    J Cardiovasc Surg (Torino); 2018 Apr; 59(2):147-149. PubMed ID: 29355296
    [No Abstract]   [Full Text] [Related]  

  • 40. Bidirectional endovascular treatment for chronic total occlusive lesions of the femoropopliteal arterial segment using a hand-carried ultrasound device and a retrograde microcatheter.
    Nishino M; Taniike M; Makino N; Kato H; Egami Y; Shutta R; Tanouchi J; Yamada Y
    J Vasc Surg; 2012 Jul; 56(1):113-7. PubMed ID: 22503184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.